CVS Health plans to split into two companies, shares down
** Shares of health insurer CVS Health CVS.N fall 2.1% to $89.47 premarket
** Co plans to separate into two independent, publicly traded companies, with completion targeted for the first half of 2028
** CVS Health CEO David Joyner will lead the insurance and health-services company, while Group President Prem Shah will become CEO of CVS Pharmacy; shareholders will own stock in both companies
** Leerink Partners says it "wouldn't be surprised" to see shares fall on deal-related factors and broader post-election volatility
** Separately, co reports Q3 adjusted EPS of $2.09, above analysts' estimate of $1.65 according to data compiled by LSEG
** Raises 2026 adjusted EPS forecast to at least $8.20 from $7.90-$8.10
** As of last close, CVS up 15.2% YTD